Advertisement

Editorial | Scientists must follow humane guidelines

  • The jailing of He Jiankui for bypassing ethical rules in an illegal gene-editing experiment should serve as a warning to others tempted to take lucrative route

Reading Time:2 minutes
Why you can trust SCMP
0
Chinese biologist He Jiankui has been jailed for his controversial experiments on human babies. Photo AFP
Scientific ambitions unguided by ethics could be the stuff of sci-fi nightmares. That was the prospect disgraced mainland scientist He Jiankui presented to the world with his shock announcement in November that his team had created the first gene-edited babies in history. Now, he and several team members have been severely punished, and deservedly so. Let this be a warning to other researchers that the drive to achieve career success is no excuse to bypass ethical rules and endanger the lives and well-being of patients.
The American-trained biophysicist has been sentenced to three years in prison and fined 3 million yuan (HK$3.4 million). Two colleagues have also been jailed and fined while others implicated in the illegal embryo-planting experiment will be blacklisted and permanently banned from related jobs. Experts were outraged when the experiment was revealed.

The scientific consensus is that the gene editing to make three babies immune to HIV was unnecessary and potentially dangerous. The court found that the experiment was unauthorised and He’s team was medically unqualified. He was found guilty of forging documents and misleading medical doctors to unknowingly implant gene-edited embryos into two women.

Wisely, Chinese authorities have moved quickly to address expert criticism by tightening regulations on genetic research, including heavy penalties for those found guilty of collecting human genetic materials without proper consent. Now, the state must ensure the welfare of the babies as they grow up as well as protect the privacy of the families involved.

He may also have been motivated by ambitions beyond science. Besides generous research grants, domestic and overseas investors had put in at least 298 million yuan in two of his biotech start-ups. The attractions of his research are obvious. The method that He used in his experiment, called CRISPR, is relatively new, fast, simple to operate and inexpensive to use. It promises potentially lucrative biotech and medical advances. Experiments on monkeys have found no signs of the technique causing unexpected mutations. As with any new science, the technique holds great promise. It is the scientists who must adhere to strict and humane guidelines.

Advertisement
Advertisement
Select Voice
Choose your listening speed
Get through articles 2x faster
1.25x
250 WPM
Slow
Average
Fast
1.25x